Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04556786 · ClinicalTrials.gov registry record · NA
A Pharmacist-led Transitions of Care Program
A NA study of Chronic Disease, sponsored by Auburn University.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT04556786: Completed NA study of Chronic Disease, sponsored by Auburn University.
NCT04556786 is a NA study of Chronic Disease that has completed, run by Auburn University. The registered enrollment target is 88 participants, below the 89,941-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04556786, a NA study of Chronic Disease, has completed, sponsored by Auburn University.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
This study was to show the value of pharmacists in providing transitions of care to and improving health outcomes of uninsured populations. It also aimed to demonstrate the feasibility of implementing a transitions of care program in an indigent care clinic with limited resources. We hypothesized that a pharmacist-led transitions of care program will reduce 30-day hospital readmission rates among the uninsured discharged from a community hospital.
Primary Outcome
Whether a study participant had any hospital readmission 30-day post-discharge
Conditions Studied
Interventions
- BEHAVIORAL Transitions of care
Study Locations (1)
Alabama
- Mercy Medical Clinic - Auburn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2018-10-02 |
| Est. Completion | 2019-07-16 |
| Phase | NA |
What the finished NCT04556786 record still lists
NCT04556786 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 89,941-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Chronic Disease appearing as the primary indexed condition, and to 1 intervention - of which Transitions of care is the first listed.
NCT04556786 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT04556786 about?
NCT04556786 is a clinical study titled "A Pharmacist-led Transitions of Care Program". This study was to show the value of pharmacists in providing transitions of care to and improving health outcomes of uninsured populations. It also aimed to demonstrate the feasibility of implementing a transitions of care program in an indigent care clinic with limited resources. We hypothesized th...
What is the current status of trial NCT04556786?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2018-10-02. Estimated completion is 2019-07-16.
What conditions does trial NCT04556786 study?
This clinical trial studies the following conditions: Chronic Disease.
What interventions are being tested in trial NCT04556786?
The interventions under investigation include: Transitions of care (BEHAVIORAL).
Who is sponsoring clinical trial NCT04556786?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04556786 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04556786's enrollment target sits among peer trials
88 34th of 48 higher than 15 of 48 other Chronic Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Click & Pick Study
RECRUITING · NA
-
Evaluation of AI Cost Prediction Model to Enroll Patients in Complex Care Management Program
RECRUITING · NA
-
Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Cancer Survivors
RECRUITING · NA
-
Comparative Effectiveness of IIMR Versus CDSMP
RECRUITING · NA
-
Training Community Members to be Coaches to Deliver the HealthyLifetime Program
RECRUITING · NA
-
Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI